In this work, a 3D-QSAR model involving for 40 dipeptidyl boronic acid proteasome inhibitors was built based on Topomer CoMFA. The multiple correlation coefficient of fitting, cross-validation and external validation were 0.908, 0.647 and 0.703, respectively. The results indicated that the obtained Topomer CoMFA model has not only the favourable estimation stability but also the good prediction capability. Topomer Search was employed as a tool for virtual screening in lead-like compounds of ZINC database. Finally, 1 R 1 group, 7 R 2 groups and 6 R 3 groups with higher contribution values were employed to alternately substitute the R 1 , R 2 and R 3 of the templete compound 23 with highest bioactivity. As a consequence, 33 new molecules with higher activity than that of the model molecule were designed successfully. The results showed that the Topomer Search technology could be effectively apply to screen and design new dipeptidyl boronic acid proteasome inhibitors and has good predictive capability to design new dipeptidyl boronic acid proteasome inhibitors drugs as guidance.
INTRODUCTION
The prominent roles of proteasome in protein degradation has made it a promising anti-cancer drug target. [1] [2] [3] Furthermore, some elevated levels of the proteasome have been involved in many diseases including cancer. Actually, it has been reported that the anticancer activity of proteasome inhibitors is due to the inhibition of the transcriptional factor NF-κB. 4, 5 Thus, the proteasome inhibitors are recognized as promising anticancer agents. 6, 7 The ubiquitin-proteasome pathway (UPP) plays a critical role in recognizing and degrading abnormal and misfolded proteins. 8, 9 Recent studies proved that this pathway played a critical role in the development of a series of human major diseases such as inflame-1026 TONG et al. mation, aging, cancer, neurodegenerative diseases, diabetes, etc. [10] [11] [12] [13] [14] Up to now, various proteasome inhibitors have been identified and developed, and several of them are widely researched in clinical trials with possibilities for clinical applications. 15 Boronic acids have been shown to be potent and specific inhibitors of serine proteases and of other enzymes. 16 , 17 Boronic acid derivatives are of considerable interest in drug development because of their moderate pH of 9-10 and air-stability. 18 The dipeptidyl boronic acid derivative Velcade ® , a proteasome inhibitor, was approved by the FDA in 2003 for the treatment of multiple myeloma disease.
In order to study and develop effective and novel dipeptidyl boronic acid proteasome inhibitors, novel strategies need to be considered and explored. Quantitative structure-activity relationships (QSAR) are computer-based mathematical models which combine the biological activity of compounds with theoretically calculated or experimental descriptors of their chemical structure. On the one hand, they are based on the concept that the activity of a substance is a function of its structure and can be determined on the basis of mathematical relationships developed from similar compounds, on the other hand, in comparison with other methods for assessing the toxicological effects of chemicals, such as animal-based and in vitro methods, QSAR models are easy to apply and efficient in terms of time and cost. In this paper, Topomer CoMFA 19 model was built based on a series of dipeptidyl boronic acid proteasome inhibitors with potent inhibitor activities. A systemic external validation was applied to evaluate the correct predictive power of the model. Finally, the obtained results from topomer CoMFA, as guidance, combining with the Topomer Search 20 were applied to conduct ligand-based virtual screening and design new dipeptidyl boronic acid proteasome inhibitor derivatives.
MATERIALS AND METHODS

Data sets
In this paper, 40 dipeptidyl boronic acid proteasome inhibitors were taken from literature. 21 The whole data set was randomly divided into the training set of 34 compounds for QSAR model construction and the test set of 6 compounds for model validation of the established model, and the test set as extra independent samples, were not involved in the model development. 22 The IC 50 values in the mmol range were converted to the mol (M) range and then to its logarithmic scale namely pIC 50 (pIC 50 = -logIC 50 ) values and used as a dependent variable for further investigation. The 3D structures of 40 dipeptidyl boronic acid proteasome inhibitors were constructed using the sketch module of the SYBYL-X 2.0 package. Partial charges for all the molecules were added using the Gasteiger-Hückel method. All molecules were optimized using the tripos force field 23 and the gradient descent method with an energy charge of 0.005 kcal * mol -1 . The maximum iteration number was 1000. The other parameters were defaulted by SYBYL-X 2.0. The structures of all the compounds along with their bioactivity values were presented in Table S 25 The molecules that were not identified needed manual fragmenting. Then the steric and electrostatic fields energy of the fragments were calculated. The chemical structure descriptors obtained were considered as the independent variables and the pIC 50 values were regarded as the dependent variables.
In this manuscript, each structure of the training set was broken into three sets of fragments, shown as R 1 (blue), R 2 (red), and R 3 (yellow) groups and one core group to generate three-dimensional conformation. Topomer CoMFA model was built by partial least square (PLS) based on the optimum number of principal components (N) 26 and evaluated by leave-one-out (LOO) cross-validation. [27] [28] [29] The test molecules were predicted by the Topomer CoMFA model to verify the predictive ability of the obtained model. Finally, the Compound Filed*Coeff field type was used in generating the field contour maps of the compounds.
The model was analyzed and evaluated by using some statistical parameters, including the cross-validated coefficient (q 2 ), the non-cross-validated correlation coefficient (r 2 ), standard error of estimate (SEE) and F-statistic values. It is widely accepted that the model has excellent predictive power when q 2 is more than 0.5 and the r 2 is not less than 0.6. The q 2 and the r 2 of the generate model was calculated using the equations as follows:
Available on line at www. where Y mean means average activity value of the entire data set, while Y obs , Y pred and Y obs represent observed, predicted and cross-validated activity values, respectively. To validate the Topomer CoMFA derived models, the predictive ability for the test set of compounds (expressed as r 2 pred ) was determined by using the following equation:
where
SD is the sum of the squared deviations between the biological activities of the test set molecules and the mean activity of the training set compounds, PRESS is the sum of the squared deviation between the observed and the predicted activities of the test set. Although not explicitly discussed, it should be noted that models have limited predictive power when the r 2 pred < 0.5.
Molecular screening
Topomer Search is a fast 3D ligand-based virtual screening tool and therefore it is able to search fragments similar to the chemical structures of the known lead compounds in large libraries of compounds. Intrinsically, it could be based on the conformational independence of Topomer similarity to carry out the whole molecule, R-groups and skeleton screening. In the present work, Topomer Search was employed to screen R-groups from ZINC molecule database (2012) 31 with 534,597 lead-like compounds in total. Topomer distance was set as 185 to evaluate the binding degree, and other parameters were defaulted by SYBYL-X 2.0.
RESULTS AND DISCUSSION
Topomer CoMFA modeling results and evaluation
The statistic results obtained from standard Topomer CoMFA model are summarized in Table I . By observing the data of the chart, we can easily find that the the r 2 value was 0.908 using 5 PLS components and the q 2 value was 0.647, F value was 55.467, r 2 pred value was 0.703, which indicated that the obtained Topomer CoMFA model have good predictive ability (q 2 > 0.5, r 2 > 0.6). The linear regression between the experimental pIC 50 and the predicted pIC 50 for the all compounds were shown in Fig. 2 . The results indicated that the model does not only have favourable estimation stability, but also has good prediction capabilities. shows that the present model has favourable simulation ability, and more accurate external predictions than the former work. The Topomer CoMFA method provides an alignment independent 3D-QSAR method, which is advantageous because it is not just being alignment-independent, but it also provides the means for automated search for activity in fragment libraries. Furthermore, the introduction of Topomer CoMFA provides a brand new method to analyze substitution of a functional group rather than of a functional atom. Thus, the work performed herein has practical meaning and far--reaching influence. 
3D contour plots of the Topomer CoMFA model
The three-dimensional contour plots of the Topomer CoMFA model are shown in Fig. 3a-f with the sample 23 as the reference structure. The contour maps were generated from a molecular field analysis when the Topomer CoMFA model is constructed. Contour maps can provide information about how to increase or decrease the bioactivity of the molecules, and different colours help to correlate the diversified steric and electrostatic fields with differences in the activity of the compounds. The electrostatic field contours are shown in red and blue while the steric field contours are shown in yellow and green. In the electrostatic field graph, the red and blue regions indicate the favourable electron--withdrawing groups and electron-donating groups, respectively. In the steric field graph, the green contours represent regions where a large or bulky substituent is favourable for the activity. The opposite stands for the yellow contours. f) electrostatic field map of R 3 (green and yellow contours represent steric favourable and unfavourable regions, respectively. While blue and red contours represent regions that favour electropositive and electronegative groups, respectively).
As shown in the Fig. 3a , a green contour covering the 1,2,3,4-tetrahydronaphthalene group linked to R 1 , indicates the presence of a bulky group, which is good for the biological activity. This is in agreement with the experimental data, e.g., by comparing chemical structures and pIC 50 values of compounds 1 (pIC 50 = = -0.28) with pyrazine group and 28 (pIC 50 = -0.37) with methyl group, the compound 1 has higher activity. Moreover, the structure and activity relationship for compounds 39 (pIC 50 = -0.08) and 40 (pIC 50 = -0.29), compounds 20 (pIC 50 = = -0.064) and 29 (pIC 50 = -0.44) supports this conclusion. Molecule 23 (pIC 50 = = 0.12) has the highest activity because of the bulky substituent at the R 1 -position. The electrostatic field contour for R 1 group (Fig. 3b) shows that the blue polyhedra region stretches around 1,2,3,4-tetrahydronaphthalene, which indicates that the electron-withdrawing group contributes to the enhancement of pIC 50 values of molecules. However, when the chemical structures and pIC 50 values of compounds 4 (pIC 50 = -0.63) and 23 (pIC 50 = 0.12) are compared, the difference in activities between compounds 4 and 23 may probably be due to some steric specifity of the receptor binding site. In Fig. 3c , there is a large blue contour around phenyl of R 2 . It can be revealed that the addition of a large volume substituent at this position increases the inhibitory activity. Comparing the compounds 21 (pIC 50 = -0. the substituent volume is, the higher is the activity of the compound, which is in accordance with the result of contour. Moreover, compounds 11 (pIC 50 = -1.59), 12 (pIC 50 = -1.15) and 13 (pIC 50 = -1.24) also support this conclusion. Fig. 3d presents the electrostatic filed contour map of R 2 fragment. There is a large blue volume region, which indicates that a bulky electron-withdrawing group could enhance the biological activity. Compound 11 (pIC 50 = -1.59) with double methyl and compound 12 (pIC 50 = -1.15) with isopropyl, compound 22 (pIC 50 = = 0.84) with double methyl and 23 (pIC 50 = 0.12) with benzene ring are also match this tendency above. In addition, the steric contour and electrostatic maps are displayed in Fig. 3e and f of R 3 fragment, respectively. The structure of R 3 group is simpler and the contribution values are smaller than the other two groups. Thus, steric and electrostatic maps are simpler than the others. According to Fig. 3e , a large green and small yellow polyhedra can be found at the side of the isopropyl, by comparing chemical structures and pIC 50 values of compounds 5(pIC 50 =-0.049) and 7(pIC 50 =-0.28), we find the former has a large R 1 group with isopropyl, while the latter has a propyl, whose volume is smaller than that of the isopropyl, which result in a higher activity value for compound 5. This illustrates that increasing the size of the substituent at this position may increase the activity of compounds. It can be seen form Fig. 3f , a small blue contour at the side of isopropyl group, indicating that the substituent with electron-withdrawing in these regions are favourable for the improvement of molecular activity. These results are in line with the pIC 50 values, 2 and 3 (4-methylphenyl = -0.68 < < 4-fluorphenyl = -0.51) where compound 2 possessed 4-methylphenyl group and displayed higher inhibitory activity than compound 3 which contained 4-fluorphenyl in R 3 -group. Compounds 9(pIC 50 = -0.83) and 10 (pIC 50 = -0.10) support the conclusion as well.
Molecular screening and molecular design
The results of the molecular screening using the Topomer Search technology were evaluated by the Topomer distance (TOPDIST) and the contribution values of R-groups (TOPCOMFA_R). In general, R groups with higher priority contribution values were used to replace the R group of template molecular in the same limit of the TOPDIST. In this work, 1958 R 1 groups, 983 R 2 groups and 1666 R 3 groups were screened. And 92 R 1 groups and 32 R 2 groups and 333 R 3 groups with higher TOPCOMFA_R than that of template molecule were selected. Finally, the 1 R 1 group, 7 R 2 groups and 6 R 3 groups with higher contribution values were employed to alternately substitute for the R 1 , R 2 and R 3 of sample 23. Then 42 new molecules were designed. All designed 42 new molecules were optimized using the method which applied to the training molecules and their activities were predicted employing the obtained Topomer CoMFA model. The structures and activities of the 42 new compounds were presented in Table II , from which could be seen that there are 9 new compounds with lower activities than that of the model molecule, as a result of the introduction of a smaller substituent group, or an electron-donating group into R 2 position of the template molecular. All the results are in agreement with the analysis of the 3D contour of the Topomer CoMFA model. 
CONCLUSION
In the present work, a Topomer CoMFA model with good internal and external prediction capability was established for a training set of 34 dipeptidyl boronic acid proteasome inhibitors and a test set of 6 molecules was employed to validate the external the model predictive ability, that we have obtained. Topomer Search was used to screen R-groups in lead-like compounds of ZINC molecule database, and 33 new molecules with higher bioactivity were successfully designed based on the rule of permutations and combinations. This study provides references to drug design for the future research of dipeptidyl boronic acid proteasome inhibitors.
SUPPLEMENTARY MATERIAL
Structures and bioactivities of the 40 dipeptidyl boronic acid derivatives are available electronically at the pages of journal website: http://www.shd.org.rs/JSCS/, or from the corresponding author on request.
